Last reviewed · How we verify
Phenylephrine Hydrochloride 8 mg
At a glance
| Generic name | Phenylephrine Hydrochloride 8 mg |
|---|---|
| Also known as | Injection Synephrine (Atco Laboratories Ltd. Pakistan |
| Sponsor | Rehman Medical Institute - RMI |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients.
- Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV (PHASE2)
- Evaluation of Oral PF614 Relative to OxyContin (PF614-102) (PHASE1)
- Effects of Intraoperative Fluid Therapy on Acute Kidney Injury After Thoracoscopic Lobectomy (NA)
- Phenylephrine in Spinal Anesthesia in Preeclamptic Patients (NA)
- Intramuscular Phenylephrine HCL for Prevention of Spinal Anesthesia Induced Hypotension (PHASE4)
- Norepinephrine Versus Phenylephrine for Preventing Spinal Anesthesia Induced Hypotension in Elderly (PHASE4)
- Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phenylephrine Hydrochloride 8 mg CI brief — competitive landscape report
- Phenylephrine Hydrochloride 8 mg updates RSS · CI watch RSS
- Rehman Medical Institute - RMI portfolio CI